---
figid: PMC6661007__nihms-1040863-f0003
figlink: /pmc/articles/PMC6661007/figure/F3/
number: F3
caption: Liver disease in autosomal recessive polycystic kidney disease (ARPKD), which
  is caused by mutations in the PKHD1 gene (encoding fibrocystin (FPC)), is characterized
  by cystic dysgenesis of the intrahepatic bile ducts that retain an immature phenotype
  reminiscent of the embryonic biliary structures (ductal plate malformations). The
  disease is associated with progressive portal fibrosis, leading to portal hypertension
  and related complications. In FPC-defective cholangiocytes, increased levels of
  cAMP activate protein kinase A (PKA)-dependent phosphorylation of β-catenin (β-Cat)
  at Ser675 that leads to the nuclear translocation of pSer675β-catenin and transcriptional
  activation. This mechanism mediates the secretion of CXC-chemokine ligand 1 (CXCL1),
  CXCL10 and CXCL12 that recruit inflammatory cells, mostly M1 and then M2 macrophages,
  around the cystic epithelium. Macrophages secrete transforming growth factor-β (TGFβ)
  and TNF and stimulate the expression of αVβ6 integrins on cystic cholangiocytes
  that in turn activate latent TGFβ. CXCL10 secretion is further increased by the
  production of IL-1β through the activation of the Janus kinase (JAK)–signal transducer
  and activator of transcription 3 (STAT3) pathway. IL-1β secretion is mediated by
  an activated inflammasome. Signalling molecules that are druggable are highlighted
  in bold and detailed in . ASC, apoptosis-associated speck-like protein containing
  a CARD; NF-κB, nuclear factor-κB; NLRP3, NOD-, LRR- and pyrin domain-containing
  3.
pmcid: PMC6661007
papertitle: 'Pathobiology of inherited biliary diseases: a roadmap to understand acquired
  liver diseases.'
reftext: Luca Fabris, et al. Nat Rev Gastroenterol Hepatol. 2019 Aug;16(8):497-511.
pmc_ranked_result_index: '88354'
pathway_score: 0.8673035
filename: nihms-1040863-f0003.jpg
figtitle: 'Pathobiology of inherited biliary diseases: a roadmap to understand acquired
  liver diseases'
year: '2019'
organisms: Homo sapiens
ndex: c0629a93-df1b-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6661007__nihms-1040863-f0003.html
  '@type': Dataset
  description: Liver disease in autosomal recessive polycystic kidney disease (ARPKD),
    which is caused by mutations in the PKHD1 gene (encoding fibrocystin (FPC)), is
    characterized by cystic dysgenesis of the intrahepatic bile ducts that retain
    an immature phenotype reminiscent of the embryonic biliary structures (ductal
    plate malformations). The disease is associated with progressive portal fibrosis,
    leading to portal hypertension and related complications. In FPC-defective cholangiocytes,
    increased levels of cAMP activate protein kinase A (PKA)-dependent phosphorylation
    of β-catenin (β-Cat) at Ser675 that leads to the nuclear translocation of pSer675β-catenin
    and transcriptional activation. This mechanism mediates the secretion of CXC-chemokine
    ligand 1 (CXCL1), CXCL10 and CXCL12 that recruit inflammatory cells, mostly M1
    and then M2 macrophages, around the cystic epithelium. Macrophages secrete transforming
    growth factor-β (TGFβ) and TNF and stimulate the expression of αVβ6 integrins
    on cystic cholangiocytes that in turn activate latent TGFβ. CXCL10 secretion is
    further increased by the production of IL-1β through the activation of the Janus
    kinase (JAK)–signal transducer and activator of transcription 3 (STAT3) pathway.
    IL-1β secretion is mediated by an activated inflammasome. Signalling molecules
    that are druggable are highlighted in bold and detailed in . ASC, apoptosis-associated
    speck-like protein containing a CARD; NF-κB, nuclear factor-κB; NLRP3, NOD-, LRR-
    and pyrin domain-containing 3.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP1
  - CASP2
  - CASP12
  - CASP14
  - JAK1
  - JAK3
  - CASP3
  - CASP4
  - JAK2
  - CASP6
  - CASP7
  - CASP8
  - CASP5
  - PYCARD
  - CXCL10
  - CXCL12
  - TGFB3
  - TGFB1
  - TGFB2
  - TYK2
  - NFKB1
  - NLRP3
  - PRKAR2B
  - PRKACA
  - PRKACB
  - CASP9
  - PRKAR2A
  - CASP10
  - CXCL1
  - PRKAR1B
  - STAT3
  - PRKACG
  - PRKAR1A
  - Ser
  - SerB
  - Biliary cirrhosis Cholangitis
  - Splenomegaly
genes:
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: ASC
  symbol: ASC
  source: hgnc_alias_symbol
  hgnc_symbol: PYCARD
  entrez: '29108'
- word: CXCL10
  symbol: CXCL10
  source: hgnc_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: CXCL12
  symbol: CXCL12
  source: hgnc_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NLRP3-
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: CXCL1
  symbol: CXCL1
  source: hgnc_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
chemicals:
- word: Ser
  source: MESH
  identifier: C530429
- word: SerB
  source: MESH
  identifier: C530429
diseases:
- word: Biliary cirrhosis Cholangitis
  source: MESH
  identifier: D008105
- word: Splenomegaly
  source: MESH
  identifier: D013163
figid_alias: PMC6661007__F3
redirect_from: /figures/PMC6661007__F3
figtype: Figure
---
